GSK layoffs 2018: what happened, why it occurred, and lasting impact
pharma-strategy
In 2018, GlaxoSmithKline (GSK) announced job cuts as part of a broader restructuring to streamline costs, refocus R&D, and strengthen its pipeline and commercial capabilities. T...
Open article